; and (3) include in such report whether, taking into consideration the factors listed in section 201(c) of the Controlled Substances Act ( 21 U.S.C. 811(c) ), as well as any potential for medical benefits, any gaps in research, and any impacts of Federal restrictions and policy on research, marijuana should be transferred to a schedule other than schedule I (if marijuana has not been so transferred already). (h) No production quotas for marijuana grown for legitimate, medical research Section 306 of the Controlled Substances Act ( 21 U.S.C. 826 ) is amended by adding at the end the following: (i) The Attorney General may only establish a quota for production of marijuana that is manufactured and distributed in accordance with the Medical Marijuana Research Act of 2017 that meets the changing medical, scientific, and industrial needs for marijuana. . (i) Article 28 of the Single Convention on Narcotic Drugs Article 28 of the Single Convention on Narcotic Drugs shall not be construed to prohibit, or impose additional restrictions upon, research involving marijuana, or the manufacture, distribution, or dispensing of marijuana, that is conducted in accordance with the Controlled Substances Act ( 21 U.S.C. 801 et seq.), this section, and the amendments made by this section. (j) No interference by Department of Justice The Attorney General, and any officer or employee of the Department of Justice, shall not interfere with the production, distribution, and sale of marijuana in accordance with this section and the amendments made by this section. 402. Provision by health care providers of the Department of Veterans Affairs of recommendations and opinions regarding veteran participation in State marijuana programs (a) Short title This section may be cited as the Veterans Equal Access Act of 2017 . (b) Authorization Notwithstanding any other provision of law, the Secretary of Veterans Affairs shall authorize physicians and other health care providers employed by the Department of Veterans Affairs— (1) to provide